Key result
Continuing antiplatelet therapy during dental surgery avoids thrombotic risk, with local measures controlling bleeding.
Why the study?
Dental management of patients on long-term oral antiplatelet therapy is not clearly defined due to the balance between thrombotic and bleeding risks during dental procedures.
Does uninterrupted antiplatelet therapy increase bleeding complications compared to discontinuation in patients undergoing dental procedures?
Does uninterrupted antiplatelet therapy increase bleeding complications compared to discontinuation in patients undergoing dental procedures?
This review summarizes existing studies and guidelines on managing antiplatelet therapy during dental procedures, balancing bleeding and thrombotic risks.
Antiplatelet management around dental procedures remains undefined; leaves open need for prospective trials to guide risk-benefit decisions.
Antiplatelet drugs are currently widely used in primary and especially secondary prevention of cardiovascular events.Dental management of patients on antiplatelet therapy is still not clearly defined: the discontinuation of antiplatelet therapy increases the risk of thrombotic complications, whereas uninterrupted antiplatelet therapy is assumed to increase the bleeding complications after dental surgical procedures.The aim of this article is to review the main antiplatelet drugs used for long-term oral antiplatelet therapy, the laboratory methods for evaluating effectiveness of this therapy, to identify the studies and guidelines available for dental management of patients on antiplatelet drugs and to summarize their conclusions and recommendations.The methodology used through the research for the literature review includes the following sources: Medscape, Pubmed-Medline database, Science Direct, and EBSCO host, the data base of Medical University Plovdiv and specialised published books in general medicine and dentistry.
No takes yet. Share an insight, caveat, or question.
Dinkova et al. (2013) conducted a review in Patients on long-term oral antiplatelet therapy requiring dental management. Continuation of oral antiplatelet therapy vs. Discontinuation of oral antiplatelet therapy was evaluated. Continuing antiplatelet medication during dental surgery is recommended, as local hemostatic measures are sufficient to control bleeding and the risk of thromboembolic events from discontinuation outweighs bleeding risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: